Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI 		Symbol Lookup | Financial Search
ARRY > SEC Filings for ARRY > Form 8-K on 8-Nov-2012All Recent SEC Filings

Show all filings for ARRAY BIOPHARMA INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ARRAY BIOPHARMA INC

8-Nov-2012

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On November 8, 2012, Array BioPharma issued a press release announcing the registration path for drug candidate, MEK162, a MEK inhibitor invented by Array and licensed to Novartis.

A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits 

Exhibit No.   Description
   99.1       Press Release announcing the registration path for drug candidate,
              MEK162, a MEK inhibitor

  Add ARRY to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ARRY - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.